Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.

Dou X, Zhou Q, Wen M, Xu J, Zhu Y, Zhang S, Xu X

Open source

DOI
10.3389/fphar.2019.01700
Published
2019
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2019.01700,
  title = {Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.},
  author = {Dou X and Zhou Q and Wen M and Xu J and Zhu Y and Zhang S and Xu X},
  year = {2019},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2019.01700},
  url = {https://doi.org/10.3389/fphar.2019.01700}
}

RIS

TY  - JOUR
TI  - Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.
AU  - Dou X
AU  - Zhou Q
AU  - Wen M
AU  - Xu J
AU  - Zhu Y
AU  - Zhang S
AU  - Xu X
PY  - 2019
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2019.01700
UR  - https://doi.org/10.3389/fphar.2019.01700
ER  - 

APA

X, D., Q, Z., M, W., J, X., Y, Z., S, Z., & X, X. (2019). Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2019.01700

Source records